• Response to The New York Times Editorial Board's Call for Federal Marijuana Legalization

    The New York Times editorial board opined in its Sunday July 27, 2014 edition that the Federal government should legalize marijuana for adults aged 21 years and older. The New York Times editorial board compares Federal marijuana policy to the failure of alcohol prohibition and advocates for legalization based on the harm inflicted on young African American men who become involved in the criminal justice system as a result of marijuana possession charges. We agree that the criminal justice system is in need of reform and that disproportionality exists throughout the system.  However, marijuana legalization is not the silver bullet solution to the issue.

    In its argument, The New York Times editorial team failed to mention a cascade of public health problems associated with the increased availability of marijuana. While law enforcement will always play an important role in combating violent crime associated with the drug trade, the Obama Administration approaches substance use as a public health issue, not merely a criminal justice problem.

    The editorial ignores the science and fails to address public health problems associated with increased marijuana use. Here are the facts:

    • Marijuana use affects the developing brain.recent study in Brain reveals impairment of the development of structures in some regions of the brain following prolonged marijuana use that began in adolescence or young adulthood.[1] Marijuana use is associated with cognitive impairment, including lower IQ among adult chronic users who began using marijuana at an early age.[2]
    • Substance use in school age children has a detrimental effect on their academic achievement. Students who received earned D’s or F’s were more likely to be current users of marijuana than those who earned A’s (45% vs. 10%).[3]         
    • Marijuana is addictive. Estimates from research suggest that about 9 percent of users become addicted to marijuana. This number increases to about 17 percent among those who start young and to 25-50 percent among people who use marijuana daily.[4]
    • Drugged driving is a threat to our roadways. Marijuana significantly impairs coordination and reaction time and is the illicit drug most frequently found to be involved in automobile accidents, including fatal ones.[5]

    The editors of The New York Times may have valid concerns about disproportionality throughout our criminal justice system.  But we as policy makers cannot ignore the basic scientific fact that marijuana is addictive and marijuana use has harmful consequences.  Increased consumption leads to higher public health and financial costs for society. Addictive substances like alcohol and tobacco, which are legal and taxed, already result in much higher social costs than the revenue they generate. The cost to society of alcohol alone is estimated to be more than 15 times the revenue gained by its taxation.[6] For this reason, the Obama Administration and the Office of National Drug Control Policy remain committed to drug use prevention, treatment, support for recovery, and innovative criminal justice strategies to break the cycle of drug use and associated crime. This approach is helping improve public health and safety in communities across the United States.

    Research also indicates that policies making drugs more available would likely not eliminate the black market or improve public health and safety, as promoted by marijuana advocates. Reports from the nonpartisan RAND Institute found that the potential economic benefits from legalization had been overstated, citing that:

    • Marijuana legalization would not eliminate the black market for marijuana.[7]
    • Dramatically lowered prices could mean substantially lower potential tax revenue for states.[8]

    We are also keeping a close eye on the states of Washington and Colorado in conformance with the directive provided by the Attorney General in August 2013.

    Any discussion on the issue should be guided by science and evidence, not ideology and wishful thinking. The Obama Administration continues to oppose legalization of marijuana and other illegal drugs because it flies in the face of a public health approach to reducing drug use and its consequences. Our approach is founded on the understanding of addiction as a disease that can be successfully prevented and treated, and from which people can recover. We will continue to focus on genuine drug policy reform – a strategy that rejects extremes, and promotes expanded access to treatment, evidence-based prevention efforts, and alternatives to incarceration.

    [1] Zalesky A, et al. 2012. Effect of long-term cannabis use on axonal fibre connectivity. Brain: A Journal of Neurology. 135 (7): 2245-2255. Available at http://brain.oxfordjournals.org/content/135/7/2245.full.pdf+html

    [2] Meier et al., “Adolescent-onset cannabis and neuropsychological health.” Proceedings of the National Academy of Sciences.   

    [August 27, 2012]. Available: http://www.pnas.org/content/early/2012/08/22/1206820109

    [3] Centers for Disease Control and Prevention, Department of Health and Human Services. Alcohol and Other Drug Use and Academic Achievement. 2010. Available at http://www.cdc.gov/healthyyouth/health_and_academics/pdf/alcohol_other_d...

    [4] Anthony, JC; Warner, LA, Kessler, RC.  1994.  Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey.  Experimental and Clinical Psychopharmacology 2:244-268.

    [5] Brady JE, Li G (2014) Trends in Alcohol and Other Drugs Detected in Fatally Injured Drivers in the United States, 199-2010,” American Journal of Epidemiology [Epub ahead of print].

    [6] Ellen E. Bouchery, Henrick J. Harwood, Jeffrey J. Sacks, Carol J. Simon, Robert D. Brewer. Economic Costs of

    Excessive Alcohol Consumption in the U.S., 2006. American Journal of Preventive Medicine - November 2011

    (Vol. 41, Issue 5, Pages 516-524, DOI: 10.1016/j.amepre.2011.06.045). Available:

    http://www.ajpmonline.org/article/S0749-3797(11)00538-1/fulltext xiii Kilmer, Beau, et al., Reducing Drug Trafficking Revenues and Viol

    [7] Kilmer, Beau, et al., Reducing Drug Trafficking Revenues and Violence in Mexico: Would Legalizing Marijuana

    in California Help? RAND Corporation. [2010]. Available:


    [8] Kilmer, Beau, et al., Altered States? Assessing How Marijuana Legalization in California Could Influence

    Marijuana Consumption and Public Budgets. RAND Corporation. [2010]. Available:



  • Women’s Addiction Forum

    Last week, I was honored to attend a bipartisan forum on women and addiction on Capitol Hill, hosted by Senators Sheldon Whitehouse (D-RI), Amy Klobuchar (D-MN), Rob Portman (R-OH), and Kelly Ayotte (R-NH). The forum focused on the unique challenges women face while suffering from substance use disorders. In my remarks, I mentioned an alarming statistic regarding drug use and pregnancy in young women. 

    Almost one in five (18.3 percent) pregnant teens aged 15 to 17 reported using an illicit drug in the past month, compared to fewer than 1 in 20 (3.4 percent) pregnant women aged 26 to 44.[i] These statistics are even more alarming in light of data from the Centers for Disease Control and Prevention indicating that the percentage of women succumbing to fatal overdoses involving opioids has risen much more sharply than that for men. From 1999 to 2011, the increase in deaths in women has risen over 400 percent, as compared to 265 percent in men.[ii] These statistics are deplorable, and for this reason, as outlined in our 2014 National Drug Control Strategy, the Obama Administration seeks to decrease drug-induced deaths by 15 percent this year through promoting strong nationwide policies that help improve access to evidence-based treatment, including medication-assisted treatment for opioid use disorders and much more.

    This week’s forum also included discussions by other individuals who brought years of experience and education on this topic to the table. Subjects of discussion included lectures on the type of treatment most effective for women, substance use disorders and motherhood, and the role of trauma as a factor contributing to substance use disorders, relapse, and recidivism in women.

    I hope to see more of these bi-partisan discussions aimed at reducing – and ultimately eliminating – the stigma associated with those suffering from or in recovery from substance use disorders. Even for people in dire need of substance use disorder treatment, stigma can be an insurmountable barrier to getting help. As a person in recovery myself, I am determined to help people get the treatment they need to live happy, healthy, and productive lives in recovery. The Obama Administration remains committed to reducing drug use and its consequences.

    [i] SAMHSA. National Survey on Drug Use and Health, 2011 and 2012. Unpublished special tabulations (September 2013).

    [ii] Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999-2011 on CDC WONDER Online Database, released 2014. Accessed at http://wonder.cdc.gov/mcd-icd10.html on Jul 25, 2014.


  • National Blueprint for Drug Policy Reform Released Today in Roanoke, VA

    Today, we will unveil the latest update to President Obama’s plan for reducing drug use and its consequences, the 2014 National Drug Control Strategy. This Strategy, which continues to be shaped by the input of people across the country like you, rejects the notion that we can arrest and incarcerate our way out of the nation’s drug problem. Instead, it builds on decades of research demonstrating that while law enforcement should always remain a vital piece to protecting public safety, addiction is a brain disorder—one that can be prevented and treated, and from which people recover.

    Data have shown that in several major U.S. counties, crime and substance use are linked. Most recently, we saw that in five counties, one-third or more of adult male arrestees tested positive for an illicit substance at the time of their arrest. Only one-quarter or fewer of all arrestees had ever participated in any outpatient drug or alcohol treatment and less than 30% had ever participated in any inpatient drug or alcohol treatment. Many of these men will be caught in a painful cycle of arrest, incarceration, substance use disorders, and re-arrest. Our prisons and jails are already overcrowded with people who desperately need compassionate, evidence-based treatment for the disease of addiction--not a jail cell.

    The plan we released today calls for reforming our criminal justice system to find alternatives to incarceration – and effective interventions across the entire system to get people the treatment they need.

    Here’s the problem: far too often, for people who need it most, the criminal justice system can seem like the only way to get help for a substance use disorder. That’s because until recently, prohibitively high costs and limited access to treatment put it out of reach for millions of people in need.

    We know that only about 10 percent of people with a diagnosable substance use disorder actually receives treatment at a specialty facility. While several factors contribute to this abysmal statistic, much of that disparity is owed to a lack of healthcare coverage – and that’s about to change. Through a rule made possible by the Affordable Care Act, we are requiring insurers to treat substance use disorders in the same way they would any other chronic disease. Specifically, this new rule expands coverage of mental health and substance use disorder services to 62 million Americans. 

    The plan we released today calls on healthcare providers to prevent and treat addictive disorders just like they would treat any other chronic disorder, like diabetes or heart disease. It calls on law enforcement, courts, and doctors to collaborate with each other to treat addiction as a public health issue, not a crime.

    We chose to release the 2014 Strategy in Roanoke because, in three important ways, it’s a microcosm of the policies our office has been promoting since 2009:

    1. Access to treatment, a focus on prevention, and compassion. Roanoke is home to one of the largest behavioral healthcare centers in the region. The center is co-located with a Drug Free Communities coalition, which prevents substance use among at-risk youth, and a program called Project Link, which helps opioid-dependent women and pregnant mothers get treatment and give birth to drug-free babies.
    2. Alternatives to incarceration. In 2011, the Roanoke Police Department worked with community and faith leaders in the Hurt Park neighborhood to shut down the open-air drug market operating there and drastically reduce violent crime in the area. As part of this intervention, community leaders came together to offer the low-level, non-violent drug offenders involved in the sweep a life-changing alternative: either face prosecution and lengthy sentences, or change your lives with the support of the community. In Roanoke, I met with one of those ex-offenders who is now employed full-time and caring for his family.
    3. Local solutions for local challenges. In a corner building in downtown Roanoke operates a community action center with roots in President Lyndon Johnson’s landmark anti-poverty legislation. Half a century ago, local leaders established what is now called Total Action for Progress (TAP), which operates 30 programs in the Roanoke Valley region aimed at improving employment opportunities at-risk youth, early childhood development, and re-entry and support services for veterans. I visited TAP to speak with young people and a veteran whose lives have been changed by these programs, and was inspired by their stories of hope. 

    Like the rest of the country, Roanoke has seen a devastating rise in heroin and prescription painkiller abuse. According to the Centers for Disease Control and Prevention, drug overdose deaths surpass homicides and traffic crashes in the number of injury deaths in America.[1] In 2011, more than 110 Americans, on average, died from overdose every day. Prescription painkillers were involved in over 16,900 deaths that year. Heroin was involved in more than 4,300.[2]

    In response to this opioid epidemic, this Strategy updates the President’s 2011 Prescription Drug Abuse Prevention Plan by calling for increased access to naloxone, a lifesaving overdose-reversal medication. 

    The widespread use of naloxone in the hands of law enforcement, firefighters and emergency medical personnel will save lives. It can also serve as a critical intervention point to get people into treatment and on the path to recovery.

    Today, there are millions of Americans in recovery from substance use disorders who are healthy, responsible, and engaged members of their communities. The Strategy outlines steps to help lift the stigma associated with substance use disorders. It also works to reform the laws and regulations that impede recovery from substance use disorders, including those that place obstacles in the way of housing, employment, and obtaining a driver’s license or student loan because of a prior conviction for a drug-related offense.

    The National Drug Control Strategy released today is rooted in the belief that illicit drug use is a public health issue, not just a criminal justice problem. As the innovative law enforcement and social support programs in Roanoke prove, this philosophy can reduce illicit drug use while building healthier, safer, more vibrant communities.

    Learn more about what’s in the 2014 National Drug Control Strategy and sign up for email updates from my office.

    Michael Botticelli is the Acting Director of National Drug Control Policy. 

    [1] National Center for Health Statistics/CDC, National Vital Statistics Report, Final death data for 2011 (June 2014).

    [2] National Center for Health Statistics/CDC, National Vital Statistics, unpublished special tabulations (June 10, 2014).


  • White House Summit on the Opioid Epidemic

    Today, Acting Director Michael Botticelli hosted Attorney General Eric Holder, Vermont Governor Peter Shumlin, Director of National Institute on Drug Abuse Dr. Nora Volkow, and two panels of experts to address the national epidemic of opioid abuse.

    The abuse of opioids, a group of drugs that includes heroin and prescription painkillers, has a devastating impact on public health and safety in this country. According to the Centers for Disease Control and Prevention (CDC), approximately 110 Americans, on average, died from drug poisoning every day in 2011.[i] Prescription drugs were involved in more than half of the 41,300 drug poisoning deaths that year, and opioid pain relievers were involved in nearly 17,000 of these deaths.[ii] There were about 4,400 drug poisoning deaths involving heroin. Drug poisoning deaths even outnumbered deaths from gunshot wounds or motor vehicle crashes.[iii]

    Corrections to previously published number of deaths involving heroin:  2009 to 2011 should be 3,279, 3,038, and 4,397 respectively (for 2009 and 2010 to include deaths involving opium and a typo for 2011).

    In his remarks, Attorney General Holder underscored the important role that law enforcement professionals play not only in reducing drug-related crime, but preventing overdose. Often, police officers are the first responders at the scene of an overdose, and their decisive action can mean the difference between life and death for an overdose victim.

    We join the Attorney General in encouraging first responders to carry the overdose-reversal drug naloxone. When administered quickly and effectively, naloxone immediately restores breathing to a victim in the throes of an opioid overdose. Used in concert with “Good Samaritan” laws,  which grant immunity from criminal prosecution to those seeking medical help for someone experiencing an overdose, naloxone can save lives. The map below shows which states currently have laws which increase access to naloxone and encourage witnesses to an overdose to call 911:

    Governor Shumlin, who previously dedicated his entire State of the State address to the opioid crisis in Vermont, outlined the steps his administration is taking to prevent and treat substance use disorders.

    Dr. Nora Volkow provided an overview of the groundbreaking advances we’ve made over the past several decades in the study of addiction – a progressive disease of the brain that can be prevented, treated and recovered from. Watch her discuss the disease of addiction:

    The opioid epidemic has already brought heartbreak to too many families across the country – but we’re not powerless to stop it. You can help – right now – by spreading the word about how to save a life and where to seek treatment. 

    Missed the summit? Watch videos of the summit here:

    Rx Drug and Heroin Epidemic in the States


    Robert Morrison
    Executive Director, National Association of State Alcohol and Drug Abuse Directors (NASADAD)

    Panel I - Prevention, Intervention and Treatment


    Dr. Hillary Kunins
    Acting Executive Deputy Commissioner, Division of Mental Hygiene, Assisting Commissioner for the Bureau of Alcohol and Drug Use, New York City Department of Health and Mental Hygiene (DOHMH)

    Dr. Traci Green
    Assistant Professor of Emergency Medicine and Epidemiology, Brown University

    Dr. Josh Sharfstein
    Secretary, Maryland Department of Health and Mental Hygiene

    Panel II: Overdose and Infectious Disease Prevention


    Nancy Hale
    Program Director, Operation UNITE

    Dr. Michelle Lofwall
    Associate Professor, Departments of Psychiatry and Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky College of Medicine

    Dr. Ed Bernstein
    Professor and Vice Chair for Academic Affairs, Emergency Medicine, Boston University School of Medicine


    [i] National Center for Health Statistics/CDC, National Vital Statistics Report, Final death data for each calendar year (June 2014)..

    [ii] National Center for Health Statistics/CDC, National Vital Statistics Report, Final death data for each calendar year (June 2014)..

    [iii] National Center for Health Statistics/CDC, National Vital Statistics Report, Final death data for each calendar year (June 2014).



  • Join the Discussion: Summit on Opioids on June 19

    The abuse of opioids – a group of drugs that includes heroin and prescription painkillers – is devastating public health and safety in communities across the nation. While the Obama Administration has been leading a comprehensive response to the prescription drug problem for more than four years, the recent uptick in heroin use across the country, and the increasing number of overdose deaths, requires a new approach.

    Michael Botticelli, Acting Director of National Drug Control Policy, will be joined by Eric Holder, U.S. Attorney General, Peter Shumlin, Governor of Vermont, Nora Volkow, Director of the National Institute on Drug Abuse, and other public health and government leaders to discuss the scope of the epidemic and strengthen collaborations across government to ensure we’re doing everything we can do prevent substance use disorders, reduce overdose deaths and treat those who are struggling with addiction.

    Please join us for this important conversation. Here’s how:

    Watch live from 9 a.m. to 12:30 p.m. on Thursday, June 19 at whitehouse.gov/live.

    Share your story and ask questions on Twitter using #OpioidSummit, and follow @ONDCP for live updates.

    Sign up for email updates for the latest news in drug policy. 

  • How a Vermont Hospital Fights the American Opioid Epidemic

    Over the course of my more than 20 years as an emergency physician, I have seen thousands of patients with painful conditions. During that same time, I have witnessed the remarkable evolution of modern pain medication – its potential and its pitfalls. We can now help patients manage both short-term and long-term pain. Yet, while medications – particularly opioids – have helped us heal patients, we have also seen their detrimental effects, chief among them addiction.

    Opioids can be very helpful for patients with conditions such as broken bones and kidney stones, and they are also useful after many types of surgery. They may also be used to treat those with chronic pain – people who experience pain carrying out normal, daily functions of life that others take for granted. Used for short periods of time at the proper dosage, opioids are safe medications and excellent choices for a wide variety of acute painful conditions.

    While opioids work well for pain control, they have a number of potentially serious side effects: They can hinder or stop breathing, cause constipation, result in drowsiness, and act as central nervous system depressants. That’s why your doctor tells you it is not safe to drive after taking opioids.

    Another devastating side effect is addiction. The body develops a tolerance to opioids and, after only a couple of weeks, may require higher doses to control pain.  Over time, increasing doses of opioids may be needed to manage the same level of pain. Patients may develop dependence – their bodies will crave it. They will exhibit a strong desire or compulsion to take the drug for reasons beyond simple pain control. At this stage, if they stop taking opioids, they will experience withdrawal. This is how opioid use can lead to addiction and all its inherent problems for the individual and society.

    As providers, our responsibility is to carefully manage the side effects of opioid therapy. Dependence, tolerance, and addiction must be discussed with patients, and a careful well-planned strategy is crucial for their extended use of opioids.

    That is exactly what we are doing at Fletcher Allen Health Care in Burlington, Vermont. Recently, providers and pain management experts from multiple specialties (Anesthesia, Emergency Medicine, Family Medicine, Internal Medicine, and Surgery) converged to standardize how we care for patients with painful conditions and to develop best practices for our patients.

    What did we do? Here is an overview:

    • Systems Approach. We built standardized protocols so that patients will get similar treatment in various settings. We believe this standardization will help our patients and providers. There will be clear, defined expectations and goals for treating our patients’ pain.
    • New Rules & Tools. We use processes and tools such as pain agreements with patients and surveys to assess how patients are functioning with their pain and to measure their risk for addiction.
    • Defining Maximum Daily Dosage. We are one of the first hospitals in the country to define the maximum daily dose of opioids. Research shows that beyond certain doses, patients experience no additional benefit. We know that very high doses of opioids increase the risk of dangerous side effects but offer no additional pain control.

    This approach helps ensure that we are more reliable and consistent in our approach to pain in our patients and that our patients will know what to expect from their providers.

    Gil Kerlikowske, then-Director of ONDCP, recently visited Fletcher Allen Health Care to discuss our new approach and tools. He lauded our systems-level strategy and our standardized protocols.

    I believe that the current dialogue in Vermont and elsewhere on how to better manage opioid abuse will be productive and lead to changes across the country in how these drugs are prescribed and how acute and chronic pain is managed. Fletcher Allen Health Care is on the leading edge of this transition and could be a model for other health systems managing this complex issue. I hope that sharing our practices here is the first step toward being that model.

    Stephen M. Leffler, M.D., is the Chief Medical Officer at Fletcher Allen, former Medical Director of the Emergency Department, and has been a practicing physician for 20 years. He grew up in Brandon, Vermont.

  • Acting Director Botticelli Addresses OAS Anti-Drug Group

    On May 1, ONDCP Acting Director Michael Botticelli spoke at the 55th regular session of the Inter-American Drug Abuse Control Commission (CICAD) in Washington, D.C. The 34 Member Nations from the Organization of American States (OAS) gathered to discuss an array of public health and drug policy issues, including drug courts and other alternatives to incarceration and the growing challenge of local distribution of drugs within Latin America, a practice known as “micro-trafficking” in Colombia, which is serving as the CICAD Chair.
    Dr. Wilson Compton, Deputy Director of the National Institute on Drug Abuse, joined Acting Director Botticelli on a panel to discuss “Health Issues and Policies related to Cannabis.” Acting Director Botticelli discussed the disease of addiction, the expanding access to drug treatment under the Affordable Care Act, and Federal monitoring of state marijuana laws in Colorado and Washington.  His remarks were followed by Dr. Compton’s detailed presentation on the current scientific understanding of marijuana’s short- and long-term effects on the brain and body.

  • Mark Your Calendar: April 26th is National Prescription Drug Take-Back Day

    This Earth Day, we encourage all Americans to take action to protect the planet while protecting their health by making plans to participate in National Prescription Drug Take-Back Day this Saturday, April 26th from 10 a.m. to 2 p.m.

    Many prescription drugs that lie unused in home medicine cabinets are highly susceptible to diversion, misuse, and abuse. Research has shown that about 70 percent of those who abused prescription pain relievers in the past year obtained them from family or friends – and often from the home medicine cabinet – the last time they used them.

    The environmentally responsible disposal of these drugs is a pillar of the Obama Administration’s plan to prevent prescription drug abuse. While you may have heard flushing your old pills down the toilet is the best way to dispose of them, that’s not necessarily true. Medicines that go down the drain end up in our water supply, where they can damage the environment. Saturday’s Take-Back Day is a convenient opportunity to get rid of unneeded medicine and prevent these drugs from entering our water supply.

    Locate a collection site near you.

    In 2010, approximately 100 people died every day from opioid drug overdoses, and prescription opioids were involved in 43 percent of those overdose deaths. Opioid drug abuse has devastated thousands of communities across the country. As ONDCP Acting Director Michael Botticelli recently put it, “This is an epidemic of the medicine cabinet.”

    If you have unneeded or expired prescription drugs at home, we strongly encourage you to drop them off at a safe, legal collection site in your neighborhood on Saturday, April 26, as part of the Drug Enforcement Administration’s (DEA) National Prescription Drug Take-Back Day.

    Take-Back Days are vital to supporting the Administration’s efforts to reduce the accessibility of illegal drugs and combat substance abuse. They provide a responsible and convenient way for people to properly dispose of their prescription drugs, and they help educate the public about the potential for their abuse. Since its launch in September 2010, the Take-Back Day initiative has resulted in the collection and proper disposal of 3.4 million pounds of medication – including 647,211 pounds collected during last year’s event.

    The Secure and Responsible Drug Disposal Act, passed by Congress in 2010, requires DEA to draft regulations that will provide for more convenient disposal of prescription drugs.  The new rule is expected to be issued before the end of the year and paves the way for an easier and environmentally responsible means of disposal in communities across the country.

    This year’s Take-Back Day will occur nationwide from 10 a.m. to 2 p.m. on Saturday, April 26th. Disposal sites will be set up in all 50 states, Washington, D.C., and U.S. territories.  Find a take-back location near you today.


  • Announcing Another Tool to Save Lives

    Today, the Food and Drug Administration approved a new drug that will build upon our work to turn back the tide of our nation’s overdose epidemic. This new product – Evzio - works by delivering a single dose of naloxone via a hand-held auto-injector that can be carried in a pocket or stored in a medicine chest for rapid access by first responders and caregivers responding to an opioid overdose. 
    Why is this so important?  Naloxone is a lifesaving overdose reversal drug that rapidly reverses the effects of opioid overdose and is currently the standard treatment for overdose.  This product is easier to administer than naloxone products that must be administered via syringe and is similar to an epi-pen. 
    The FDA’s approval of another overdose reversal drug could not come at a more urgent time.   Drug overdose deaths, driven largely by prescription drug overdose, are now the leading cause of injury death in the United States – surpassing motor vehicle crashes.
    There are no silver bullet solutions to our nation’s overdose epidemic. Prevention, treatment, and smart on crime efforts each play a vital role in protecting public health and safety in America.  Working together, we can save lives and strengthen our nation’s ability to prosper.

  • Join Us for Launch of the Updated Viral Hepatitis Action Plan on Thursday, April 3

    This is a cross-post from AIDS.gov. The original post can be found here
    Next Thursday, April 3, 2014, we will launch the three-year update (2014-2016) of the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. The plan provides a framework around which both federal and nonfederal stakeholders from many sectors can engage to strengthen the nation’s response to viral hepatitis. The event will be streamed online live from HHS headquarters in Washington, DC, so that as many federal, state, and community-based partners across the country as possible can participate.
    Please join us for the launch event, which can be viewed live online at www.hhs.gov/live on Thursday, April 3, 2014 from 12:00 PM – 3:00 PM (Eastern). Invite others to watch with you so you can talk about how you can work together in your community to improve viral hepatitis prevention, screening, and treatment.
    The launch event is the culmination of efforts by colleagues from across the Department of Health and Human Services as well as at the Departments of Justice, Housing and Urban Development, and Veterans Affairs who have worked within their respective agencies and offices as well as with one another to develop this framework for focused activity by both federal and nonfederal stakeholders. Federal colleagues have identified more than 150 important actions their agencies and offices will undertake between 2014 and 2016 across six priority areas.
    More than 100 nonfederal stakeholders shared thoughts, general principles, and specific recommendations that helped to shape the renewed plan over the course of its development.  A notable feature of the plan is a list of potential opportunities for non-federal stakeholders that would promote successful implementation. These implementation opportunities make it crystal-clear that achieving the goals of this national plan will require the time, talent, and energy of a broad mix of partners from across all sectors of society. The launch event will feature two panels – governmental and community – that will discuss, in practical terms, implementation challenges and opportunities as well as remarks by Assistant Secretary for Health Howard Koh, MD, MPH.

    The updated plan organizes actions around the following six priority areas:

    1:  Educating Providers and Communities to Reduce Viral Hepatitis-related Health Disparities
    Confront viral hepatitis by breaking the silence.

    2:  Improving Testing, Care, and Treatment to Prevent Liver Disease and Cancer

    Take full advantage of existing tools.

    3:  Strengthening Surveillance to Detect Viral Hepatitis Transmission and Disease

    Collect accurate and timely information to get the job done.

    4:  Eliminating Transmission of Vaccine-Preventable Viral Hepatitis

    Take full advantage of vaccines that can prevent hepatitis A and B.

    5:  Reducing Viral Hepatitis Associated with Drug Use

    Stop the spread of viral hepatitis associated with drug use.

    6:  Protecting Patients and Workers From Health Care-Associated Viral Hepatitis

    Quality health care is safe health care

    The day of the launch event, the updated Viral Hepatitis Action Plan and other information will be posted to the Viral Hepatitis Action Plan page hosted by aids.gov.

    Please join us for this event to learn more and help us kick-off this renewed plan that can improve our nation’s response to viral hepatitis. Together, we can prevent new infections and save many lives.

    Dr. Ronald Valdiserri is the Deputy Assistant Secretary for Health, Infectious Diseases and Director, Office of HIV/AIDS and Infectious Disease Policy.